A Prospective Observational Study of Osimertinib for Chemo-Naive Elderly Patients with EGFR Mutation-Positive Non-Small Cell Lung Cancer

BACKGROUND: The clinical outcomes of elderly patients with EGFR-mutated non-small cell lung cancer (NSCLC) who are treated with osimertinib have not been sufficiently evaluated. This study aimed to assess the efficacy and safety of osimertinib in elderly chemotherapy-naive patients with NSCLC harbor...

Descripción completa

Detalles Bibliográficos
Autores principales: Igawa, Satoshi, Kasajima, Masashi, Ono, Taihei, Ozawa, Takahiro, Kakegawa, Mikiko, Kusuhara, Seiichiro, Sato, Takashi, Nakahara, Yoshiro, Fukui, Tomoya, Yokoba, Masanori, Kubota, Masaru, Mitsufuji, Hisashi, Sasaki, Jiichiro, Naoki, Katsuhiko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8612658/
https://www.ncbi.nlm.nih.gov/pubmed/34849025
http://dx.doi.org/10.2147/CMAR.S339891

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8612658/
https://www.ncbi.nlm.nih.gov/pubmed/34849025
http://dx.doi.org/10.2147/CMAR.S339891

Ejemplares similares